Literature DB >> 27086229

Correlates of transient versus persistent psychotic symptoms among dependent methamphetamine users.

Rebecca McKetin1, Jonathon Gardner2, Amanda L Baker3, Sharon Dawe4, Robert Ali5, Alexandra Voce2, Liana S Leach2, Dan I Lubman6.   

Abstract

This study examined correlates of transient versus persistent psychotic symptoms among people dependent on methamphetamine. A longitudinal prospective cohort study of dependent methamphetamine users who did not meet DSM-IV criteria for lifetime schizophrenia or mania. Four non-contiguous one-month observation periods were used to identify participants who had a) no psychotic symptoms, (n=110); (b) psychotic symptoms only when using methamphetamine (transient psychotic symptoms, n=85); and, (c) psychotic symptoms both when using methamphetamine and when abstaining from methamphetamine (persistent psychotic symptoms, n=37). Psychotic symptoms were defined as a score of 4 or greater on any of the Brief Psychiatric Rating Scale items of suspiciousness, hallucinations or unusual thought content. Relative no psychotic symptoms, both transient and persistent psychotic symptoms were associated with childhood conduct disorder and comorbid anxiety disorders. Earlier onset methamphetamine use and being male were more specifically related to transient psychotic symptoms, while a family history of a primary psychotic disorder and comorbid major depression were specifically related to persistent psychotic symptoms. We conclude that there are overlapping but also distinct clinical correlates of transient versus persistent psychotic symptoms, suggesting potentially heterogeneous etiological pathways underpinning the psychotic phenomena seen amongst people who use methamphetamine.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Amphetamine; Amphetamine-related disorders; Central nervous system stimulants; Hallucinations; Paranoia; Psychotic disorders; Street drugs

Mesh:

Substances:

Year:  2016        PMID: 27086229     DOI: 10.1016/j.psychres.2016.02.038

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  8 in total

1.  Latent Psychotic Symptom Profiles Amongst People Who Use Methamphetamine: What Do They Tell Us About Existing Diagnostic Categories?

Authors:  Rebecca McKetin; Alexandra Voce; Richard Burns; Robert Ali; Dan I Lubman; Amanda L Baker; David J Castle
Journal:  Front Psychiatry       Date:  2018-11-19       Impact factor: 4.157

Review 2.  A Review of Risk Factors for Methamphetamine-Related Psychiatric Symptoms.

Authors:  Xiangwen Chang; Yan Sun; Yang Zhang; Jiana Muhai; Lin Lu; Jie Shi
Journal:  Front Psychiatry       Date:  2018-11-16       Impact factor: 4.157

Review 3.  Substance-Induced Psychoses: An Updated Literature Review.

Authors:  Alessio Fiorentini; Filippo Cantù; Camilla Crisanti; Guido Cereda; Lucio Oldani; Paolo Brambilla
Journal:  Front Psychiatry       Date:  2021-12-23       Impact factor: 4.157

4.  'The Drugs Did For Me What I Couldn't Do For Myself': A Qualitative Exploration of the Relationship Between Mental Health and Amphetamine-Type Stimulant (ATS) Use.

Authors:  Liam Patrick Spencer; Michelle Addison; Hayley Alderson; William McGovern; Ruth McGovern; Eileen Kaner; Amy O'Donnell
Journal:  Subst Abuse       Date:  2021-12-06

Review 5.  The Role of Chinese Herbal Therapy in Methamphetamine Abuse and its Induced Psychiatric Symptoms.

Authors:  Lin Chen; Qin Ru; Qi Xiong; Mei Zhou; Kai Yue; Yuxiang Wu
Journal:  Front Pharmacol       Date:  2021-05-10       Impact factor: 5.810

6.  Epidemiological Characteristics and Risk Factors of Methamphetamine-Associated Psychotic Symptoms.

Authors:  Meng-Fan Su; Mo-Xuan Liu; Jin-Qiao Li; Julia M Lappin; Su-Xia Li; Ping Wu; Zhi-Min Liu; Jie Shi; Lin Lu; Yanping Bao
Journal:  Front Psychiatry       Date:  2018-10-12       Impact factor: 4.157

7.  Behavioral and Serotonergic Changes in the Frontal Cortex Following Methamphetamine Self-Administration.

Authors:  Lisa M McFadden; Rebecca Cordie; Tamee Livermont; Andrew Johansen
Journal:  Int J Neuropsychopharmacol       Date:  2018-08-01       Impact factor: 5.176

8.  Club Drugs and Psychiatric Sequelae: An Issue of Vulnerability and Previous Psychiatric History.

Authors:  Giovanni Martinotti; Cristina Merino Del Villar; Andrés Garcia Cordoba; Lluís Andrés Tubau; Ivan Castro Sánchez; Francesco Di Carlo; Stefania Chiappini; Mauro Pettorruso; Fabrizio Schifano; Massimo Di Giannantonio
Journal:  Int J Environ Res Public Health       Date:  2021-06-29       Impact factor: 3.390

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.